|
⚲
|
| Keyboard |
| Thomas Malley | |
|---|---|
| Firm | |
| Address | 12730 High Bluff Drive, Suite 400 San Diego, CA 92130 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| KURA Oncology Inc | 021-504346 | Director | 150.0 M of 150.0 M |
||
| Kiniksa Pharmaceuticals Ltd | 021-336499 | Director | 8.8 M of 8.8 M |
||
| OvaScience Inc | 021-194187 | Director | 35.0 M of 35.0 M |
||
| PUMA Biotechnology Inc | 021-169466 | Director | 5.0 M of 5.0 M |
||
| PUMA Biotechnology Inc | 021-166750 | Director | 55.0 M of 55.0 M |
||
| PUMA Biotechnology Inc | 021-166756 | Director | 70.0 M of 70.0 M |
||
| Synageva Biopharma Corp | 021-157597 | Director | 12.5 M of 25.0 M |
||
| Azahar Place Associates LP | 021-155722 | Executive Officer | 1.2 M of 10.3 M |
||
| Camino Gonzalez Associates LP | 021-153490 | Executive Officer | 5.8 M of 5.8 M |
||
| Plaza Amistad Associates II LP | 021-152546 | Executive Officer | of 3.2 M |
||
| Plaza Amistad Associates LP | 021-146586 | Executive Officer | 7.3 M of 7.3 M |
||
| Synageva Biopharma Corp | 021-66553 | Director | 45.0 M of 45.0 M |
||